Volume 32, Number 6—June 2026
CME ACTIVITY - Synopsis
Cerebrospinal Fluid Findings among Patients with Anaplasmosis and Central Nervous Involvement, Minnesota and Wisconsin, USA
Table 1
Characteristics and cerebrospinal fluid findings among patients with anaplasmosis and central nervous system involvement, Minnesota and Wisconsin, USA*
| Patient no. | Age, y/sex | Immune status |
Neurologic manifestation | Sepsis | ICU admission | Cerebrospinal fluid results |
||||
|---|---|---|---|---|---|---|---|---|---|---|
| Color | Leukocyte count† | Leukocyte type (%) | Protein, mg/dL‡ | Glucose, mg/dL§ | ||||||
| 1 |
75/M |
IC |
Left hemiparesis, meningitis |
N |
N |
Clear |
5 |
Lymphocyte (40) |
48 |
56 |
| 2 |
65/F |
IC |
Meningitis |
Y |
Y |
Clear |
1 |
Lymphocyte (78) |
33 |
81 |
| 3 |
74/F |
IC |
Meningitis, akathisia |
N |
N |
Clear |
1 |
Lymphocyte (83) |
33 |
67 |
| 4 |
57/M |
IS |
Meningitis |
N |
N |
Clear |
0 |
NA |
31 |
61 |
| 5 |
57/M |
IS |
Meningitis |
Y |
Y |
Clear |
50 |
Lymphocyte (78) |
40 |
58 |
| 6 |
67/F |
IC |
Meningitis |
N |
N |
Clear |
1 |
Lymphocyte (72) |
34 |
66 |
| 7 |
60/M |
IC |
Meningoencephalitis |
N |
N |
Clear |
15 |
Lymphocyte (43); neutrophils (30) |
27 |
53 |
| 8 |
60/F |
IC |
Meningoencephalitis |
Y |
Y |
Bloody |
198 |
Neutrophils (71) |
18 |
60 |
| 9 |
70/F |
IC |
Meningoencephalitis |
N |
N |
Clear |
1 |
Lymphocyte (72) |
33 |
80 |
| 10 | 70/M | IC | Encephalitis | Y | Y | Clear | 10 | Lymphocyte (50) | 189 | 43 |
*IC, immunocompetent; ICU, intensive care unit; IS, immunosuppressed; NA, not applicable. †Reference range 0. ‡Reference range <50 mg/dL. §Reference range 36–101 mg/dL.
1These first authors contributed equally to this article.
Page created: March 30, 2026
Page updated: May 29, 2026
Page reviewed: May 29, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.